Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequately Controlled Asthma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Post-approval studies (Phase 4)Study completedNCT00454051
What this trial is testing

Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 31
Large-scale testing (Phase 3)Study completedNCT04609904
What this trial is testing

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

Who this might be right for
Asthma
AstraZeneca 2,187
Testing effectiveness (Phase 2)Ended earlyNCT01397201
What this trial is testing

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)

Who this might be right for
Asthma
Boehringer Ingelheim 30
Post-approval studies (Phase 4)Study completedNCT00267202
What this trial is testing

Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma

Who this might be right for
Allergic Asthma
Novartis 275
Testing effectiveness (Phase 2)Study completedNCT03688074
What this trial is testing

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

Who this might be right for
AsthmaBronchial DiseasesRespiratory Tract Diseases+6 more
AstraZeneca 116
Testing effectiveness (Phase 2)Ended earlyNCT01396278
What this trial is testing

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Who this might be right for
Asthma
Boehringer Ingelheim 9
Testing effectiveness (Phase 2)Study completedNCT00330070
What this trial is testing

Control of Asthma Patients Symptomatic on Inhaled Corticosteroids

Who this might be right for
Asthma
Inflazyme Pharmaceuticals Ltd 200
Testing effectiveness (Phase 2)Study completedNCT01018550
What this trial is testing

AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma

Who this might be right for
Asthma
Amgen 397
Large-scale testing (Phase 3)Study completedNCT00565266
What this trial is testing

Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)

Who this might be right for
Asthma
Milton S. Hershey Medical Center 210
Large-scale testing (Phase 3)Study completedNCT00079937
What this trial is testing

Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 628
Testing effectiveness (Phase 2)Study completedNCT01836471
What this trial is testing

Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

Who this might be right for
Asthma
Novartis Pharmaceuticals 345
Large-scale testing (Phase 3)Study completedNCT04937387
What this trial is testing

Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma

Who this might be right for
Asthma
GlaxoSmithKline 359
Testing effectiveness (Phase 2)Study completedNCT01582503
What this trial is testing

MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Who this might be right for
Asthma
Genentech, Inc. 578
Large-scale testing (Phase 3)Looking for participantsNCT05757102
What this trial is testing

Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Who this might be right for
Asthma
GlaxoSmithKline 292
Testing effectiveness (Phase 2)Ended earlyNCT03944707
What this trial is testing

Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients

Who this might be right for
Asthma
Novartis Pharmaceuticals 76